Oil prices post first weekly gain since mid-April on trade optimism, Iran sanctions
https://seekingalpha.com/news/4446110-oil-prices-post-first-weekly-gain-since-mid-april-on-trade-optimism-iran-sanctions?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
May 09, 2025 -
0
AstraZeneca, Daiichi post late-stage trial win for Enhertu in early-stage breast cancer
https://seekingalpha.com/news/4443564-astrazeneca-marks-enhertu-trial-win-breast-cancer?source=feed_sector_healthcare
May 07, 2025 -
0
Hims & Hers struggles post market despite strong Q1 results and 2025 outlook
https://seekingalpha.com/news/4441488-despite-strong-q1-results-2025-outlook-hims-and-hers-struggles-post-market?source=feed_sector_healthcare
May 05, 2025 -
0
American Well Q1 beats propel 14% post-market stock surge
https://seekingalpha.com/news/4439730-american-well-q1-beats-propel-14-post-market-stock-surge?source=feed_sector_healthcare
May 01, 2025 -
0
Amgen beats on both lines and reaffirms guidance; stock flat post market
https://seekingalpha.com/news/4439678-amgen-beats-both-lines-and-reaffirms-guidance-stock-flat-post-market?source=feed_sector_healthcare
May 01, 2025 -
0
GM posts strong Q1 results, but will reassess expectations for 2025 due to auto tariffs
https://www.sandiegouniontribune.com/2025/04/29/general-motors-results/
Apr 29, 2025 - GM said its initial full-year financial forecast doesn’t contemplate the potential impact of tariffs.
0
The FXI ETF: The Risk-Reward Profile For Chinese Stocks Post Liberation Day
https://seekingalpha.com/article/4778926-the-fxi-etf-the-risk-reward-profile-for-chinese-stocks-post-liberation-day?source=feed_tag_etf_portfolio_strategy
Apr 28, 2025 -
0
Journalism favored after drawing No. 8 post for Kentucky Derby
https://www.ocregister.com/2025/04/26/journalism-favored-after-drawing-no-8-post-for-kentucky-derby/
Apr 26, 2025 - The No. 8 post position is tied for the second-most victories in horse racing's marquee event while Bob Baffert returns to Churchill Downs after four-year ban.
0
J&J posts mid-stage trial data for chemotherapy releasing system in bladder cancer
https://seekingalpha.com/news/4436055-jj-updates-trial-data-bladder-cancer-drug?source=feed_sector_healthcare
Apr 26, 2025 -
0
PAVmed, Lucid post encouraging results from EsoGuard study
https://seekingalpha.com/news/4435006-lucid-reports-encouraging-results-from-esoguard-study?source=feed_sector_healthcare
Apr 24, 2025 -
0